Skip to main content

Adamas to Present at Upcoming Needham Conference

Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on April 12 – 15, 2021.

The fireside chat will be webcast live on April 14 from 3:00 Eastern Time on the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. The replay will be available for 30 days.

About Adamas Pharmaceuticals, Inc.

At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and, society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.

Source: Adamas Pharmaceuticals, Inc.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  204.79
+3.64 (1.81%)
AAPL  264.35
+0.47 (0.18%)
AMD  200.12
-2.96 (-1.46%)
BAC  53.36
+0.62 (1.18%)
GOOG  303.94
+1.12 (0.37%)
META  643.22
+3.93 (0.61%)
MSFT  399.60
+2.74 (0.69%)
NVDA  187.98
+3.01 (1.63%)
ORCL  156.17
+2.20 (1.43%)
TSLA  411.32
+0.69 (0.17%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.